1. Home
  2. PLOW vs XERS Comparison

PLOW vs XERS Comparison

Compare PLOW & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Dynamics Inc.

PLOW

Douglas Dynamics Inc.

HOLD

Current Price

$44.31

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$6.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLOW
XERS
Founded
1948
2005
Country
United States
United States
Employees
1764
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
PLOW
XERS
Price
$44.31
$6.17
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$51.50
$10.83
AVG Volume (30 Days)
256.5K
1.6M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
2.67%
N/A
EPS Growth
N/A
100.00
EPS
0.26
0.01
Revenue
$656,053,000.00
$49,590,000.00
Revenue This Year
$13.71
$34.37
Revenue Next Year
$5.36
$22.86
P/E Ratio
$166.96
$638.48
Revenue Growth
15.40
142.67
52 Week Low
$27.13
$4.30
52 Week High
$52.33
$10.08

Technical Indicators

Market Signals
Indicator
PLOW
XERS
Relative Strength Index (RSI) 48.29 49.57
Support Level $40.95 $5.79
Resistance Level $47.58 $6.41
Average True Range (ATR) 2.01 0.32
MACD -0.28 -0.02
Stochastic Oscillator 20.87 28.51

Price Performance

Historical Comparison
PLOW
XERS

About PLOW Douglas Dynamics Inc.

Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: